NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioCam

BioCam

Private
PolandHealthcare & Life Scienceshttps://www.biocam.ai/

Last Round

Seed

May 11, 2023

Total Funding Raised

$2.85M

Company Overview

BioCam is a healthtech company that develops innovative remote capsule endoscopy technology and AI-powered software for the non-invasive diagnosis of the gastrointestinal tract in humans and animals.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

ingestible capsule endoscopepill camgastrointestinal diagnosticsmedical AIcapsule endoscopyAI image analysisnon-invasive endoscopygastroenterology softwaredigital healthmedical imagingdiagnostic softwaretelemedicine platformmedtechhealthcare analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioCam Comparables

Compare BioCam with similar companies based on industry and business-model similarity.

BioCam comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chongqing Jinshan Science & Technology (Group) Co., Ltd.
86%
AnX Robotica
83%
Medtronic
78%

BioCam Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 11, 2023
GrantOct 31, 2021
Pre SeedMay 8, 2020
GrantMay 8, 2020

Key People

Founding team and executive leadership

Maciej Wysocki

CEO and co-founder

Founding Team

Marek Szmigiel

COO & CCO

Executive Team

BioCam Investors

Notable investors and investment history

BioCam investors
InvestorRounds
Level2 VenturesSeed
LT CapitalPre Seed
National Centre for Research and DevelopmentGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Grew 21% QoQ, from 29 to 35 employees.

  • May 11, 2023

    $480K round led by Level2 Ventures

BioCam Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioCam Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioCam's valuation, stock price, and market status.

Firmographic Details

HeadquartersPoland
Employee Range34
Year Founded2019
Last FundingMay 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.